HealthQuill Kidney Diseases
The US Food and Drug Administration has approved Apellis Pharmaceuticals, Inc.’s medicine for treating two rare and serious kidney diseases.
Drugs Health Pharma

FDA approves Apellis’ therapy to treat two serious, rare kidney diseases

HQ Team July 30, 2025: The US Food and Drug Administration has approved Apellis Pharmaceuticals, Inc.’s medicine for treating two rare and serious.

Read More
Kidney cells placed in an implantable device in pigs can mimic several functions of the organ without triggering the recipient’s immune system to attack, scientists found.
Drugs Health Pharma

UCSF scientists mold a ‘bioreactor’ to replace dialysis

HQ Team September 2, 2023: Kidney cells placed in an implantable device in pigs can mimic several functions of the organ without triggering.

Read More
SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk and immunocompromised patients.
Drugs Medical Pharma

SAB gets FDA fast track nod for experimental drug to treat influenza

HQ Team April 14, 2023: SAB Biotherapeutics got a fast-track designation from the USFDA for its investigational drug to treat influenza in high-risk.

Read More